SignalXSignalX

NVAX NOVAVAX INC

8-K Current Report
Filed: February 26, 2026
Health Care
Biological Products, (No Diagnostic Substances)
NOVAVAX INC Overview

NOVAVAX INC (NVAX) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q4 2025 earnings release issued Feb 26, 2026 — covers quarter ended Dec 31, 2025
  • • Full financial details in Exhibit 99.1 of this 8-K filing

Get deeper insights on NOVAVAX INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.